Two Too Hard On Soft-Tissue Cancers
Cancers that appear in the soft tissues of the body are very rare. In fact, they are seen in only about 5 people out of every 100,000. A recent study looked at the best way to treat this cancer.
Sugar-Free Cancer Therapy
Kaposi sarcoma (KS) is a soft-tissue cancer that’s associated with a herpes virus. KS is seen in many people who are HIV positive. The tumors show up as purple, red or brown spots. A new treatment for this condition could be in the works.
Who Wants To Live In A Toxic World?
Pancreatic cancer is one of the most aggressive. Combination chemotherapy has been the treatment mainstay for advanced disease. Now this approach is being questioned.
Talking to Kids About Cancer
Nick Gonzalez is a Child Life Specialist. He talks and plays with kids who have cancer every day. These infants, toddlers, kids, adolescents and young adults come to the Dell Children’s Medical Center in Austin, Texas to be treated - mostly for leukemia, or for brain tumors or soft tissue cancers.
AIDS and Cancer Links
People living with HIV (human immunodeficiency virus) are at greater risk of various forms of cancer. In fact, when these cancers appear, it means the virus has turned into full-blown AIDS (acquired immunodeficiency syndrome).
Greater Access to GIST Rx During FDA Review
Gastrointestinal stromal tumors (GIST) are known as soft tissue sarcomas. They can appear anywhere along the digestive tract. They most commonly start in the stomach. A new drug to treat GIST is headed for review by the U.S. Food and Drug Administration (FDA).
The Big Finish for Sarcoma
Drug research takes years of development, and there comes a day when hard data reveals whether the drug actually works the way it did in the lab.
A Hard Look at Soft Cancers
Sometimes when you go to the doctor, you wonder - how do they keep up with all the recent research and treatment options for all of this stuff? How do they know how chemotherapies stack up against each other?
Head and Neck Cancer Presentation Highlights
A recent presentation at the American Society of Clinical Oncology expanded on several molecular breakthroughs concerning head and neck cancers, and a team of doctors gave an overview of recent conclusions from their respective fields.
Home Run for Pediatric Cancer Drug
An early study looking at a treatment for cancers involving a certain gene mutation had better results than expected, with findings showing that no traces of cancer are detectable in some of the patients in the drug trial.